KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kimbell Royalty Partners (KRP) Liabilities and Shareholders Equity (2016 - 2025)

Kimbell Royalty Partners (KRP) has 10 years of Liabilities and Shareholders Equity data on record, last reported at $1.2 billion in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 9.77% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $5.1 billion, up 4.63%, while the annual FY2025 figure was $1.2 billion, 9.77% up from the prior year.
  • Liabilities and Shareholders Equity reached $1.2 billion in Q4 2025 per KRP's latest filing, down from $1.3 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $1.4 billion in Q3 2023 and bottomed at $557.0 million in Q3 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $1.0 billion, with a median of $1.1 billion recorded in 2022.
  • Peak YoY movement for Liabilities and Shareholders Equity: fell 19.56% in 2021, then surged 79.01% in 2022.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $601.5 million in 2021, then soared by 79.01% to $1.1 billion in 2022, then grew by 24.24% to $1.3 billion in 2023, then dropped by 16.29% to $1.1 billion in 2024, then increased by 9.77% to $1.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $1.2 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.3 billion in Q2 2025.